Barbara Oil Co. increased its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 100.0% in the 2nd quarter, Holdings Channel.com reports. The firm owned 3,390 shares of the biotechnology company’s stock after buying an additional 1,695 shares during the quarter. Barbara Oil Co.’s holdings in Axon Enterprise were worth $2,046,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV acquired a new position in shares of Axon Enterprise in the fourth quarter worth about $28,000. Keating Financial Advisory Services Inc. bought a new stake in Axon Enterprise during the second quarter valued at $31,000. AlphaCentric Advisors LLC bought a new stake in shares of Axon Enterprise during the 4th quarter valued at about $34,000. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 2nd quarter worth approximately $37,000. Finally, Washington Trust Advisors Inc. raised its position in shares of Axon Enterprise by 1,300.0% during the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after purchasing an additional 65 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, President Joshua Isner sold 16,775 shares of the company’s stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $574.43, for a total value of $9,636,063.25. Following the completion of the sale, the president directly owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. This represents a 5.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 9,930 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $548.77, for a total transaction of $5,449,286.10. Following the completion of the transaction, the chief executive officer owned 3,031,067 shares of the company’s stock, valued at $1,663,358,637.59. This trade represents a 0.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 56,380 shares of company stock worth $32,582,366. 4.20% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Axon Enterprise
Axon Enterprise Stock Performance
Shares of AXON stock opened at $490.00 on Thursday. The business has a 50 day simple moving average of $566.39 and a 200 day simple moving average of $488.10. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. The firm has a market capitalization of $39.81 billion, a price-to-earnings ratio of 203.32, a price-to-earnings-growth ratio of 9.86 and a beta of 1.40. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $792.16.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company’s quarterly revenue was up 35.3% compared to the same quarter last year. During the same period last year, the company earned $2.12 earnings per share. On average, equities research analysts anticipate that Axon Enterprise, Inc will post 2.04 EPS for the current year.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and equipment for law enforcement, public safety and other government agencies. Its product portfolio includes TASER energy weapons, body-worn cameras, in-car cameras and related connected devices designed to support safer interactions, improve transparency and collect operational data.
The company also provides cloud-based software for managing digital evidence, conducting investigations, overseeing records and workflows, coordinating dispatch and supporting real-time public safety operations.
Read More
- Five stocks we like better than Axon Enterprise
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
